Pages
Products
Services
CBpromise

Our promise to you:
Guaranteed product quality, expert customer support.

24x7 CUSTOMER SERVICE
CONTACT US TO ORDER

Aptamer Discovery & SELEX Solutions

Brief Introduction


Creative Biogene is one of the leading biotechnology companies providing a full range of services to develop high quality customized aptamers for research, diagnostic and therapeutic applications.

Aptamer in Biosensor Aptamer in Biosensor

DNA Aptamer DNA Aptamer

Peptide Aptamer Peptide Aptamer

RNA Aptamer RNA Aptamer

Aptamers are stable single-stranded RNA or DNA Oligonucleotides that binds with high affinity and specificity to a wide range of targets such as small organics, peptides, proteins, carbohydrates, small molecules, ions, viruses, cells, and tissues.

Aptamers Service

Creative Biogene offers custom aptamer development services for your scientific research as follows:

  • Selection is an in vitro process that can target any small molecule, biopolymer, or cell.
  • Uniform activity regardless of the batch.
  • Aptamers can be rapidly produced in large quantities with easy quality control
  • High stability
  • High specificity, aptamers can discriminate enantiomers and protein isoforms
  • Affinity parameters can be controlled on demand
  • Wide variety of chemical modifications are introduced to diversify properties and functions
  • Unlimited shelf-life
  • No evidence of immunogenicity

Aptamers have been attracting more and more attention within life science research and applications owing to these advantages over antibody. Aaptamers are playing their roles in ELISAS, Westerns, Flow Cytometry & Microarrays and are hopeful to replace antibodies in all of the areas currently dominated by antibodies. Moreover, there is one aptamer approved by FDA and several other candidates are currently in clinical trials. Thus, aptamers possess encouraging prospects.

Case Study

Schematic illustration of the magnetic immunofiltration assay as described by Rettcher et al. (2015). Schematic illustration of the magnetic immunofiltration assay as described by Rettcher et al. (2015).

In-field molecular diagnosis of plant pathogens: recent trends and future perspectives

Paper 2018
Plant Pathology | DOI
Background
This review examines promising techniques for in-field molecular detection of plant pathogens, emphasizing rapid, specific, and user-friendly point-of-care diagnosis. It discusses simplified DNA extraction, reagent stabilization, portable devices, LAMP, RPA, multiplex immunodetection, aptamers, AC dielectrophoresis, and nanopore sequencing. While some methods are validated, most require further plant pathology validation. Combining these tools with portable platforms could enable early disease detection, improve crop management, reduce laboratory dependence, and support timely control decisions.
Key Findings
The review finds that early, accurate detection is essential; traditional culture/morphology and lab-based PCR/ELISA are limited by time, cost, and infrastructure. Promising in-field techniques include LAMP and RPA (isothermal, rapid 10-45 min), multiplex microsphere immunoassays, aptamer-based sensors, AC dielectrophoresis, and portable nanopore sequencing (MinION). Simplified DNA extraction (PEG-OH, FTA cards) and reagent stabilization (trehalose, lyophilization) enable field use. LAMP/RPA have been validated for fungi, bacteria, viruses; MIAs for viruses; aptamers for fungi/viruses; AC-DEP and MinION not yet validated on plant pathosystems. Challenges include distinguishing viable/dead cells (PMA can help), cost, internet dependence, and sample preparation. The authors conclude that combining these technologies with portable devices could shift diagnosis to the field, allowing farmers/advisors faster response, though expert guidance remains important.
Contribution
The article identifies Creative Biogene as a commercial provider of aptamer discovery and development services, alongside other companies. By offering SELEX-based aptamer selection, it helps researchers save time in diagnostic development; the review cites aptamer service costs (~$5000) and notes low production costs, supporting aptamer-based plant pathogen diagnostics.
* For research use only. Not intended for any clinical use.
Quick Inquiry